ANDRÉS JESÚS
MUÑOZ MARTÍN
Profesor asociado de Ciencias de la Salud
Hospital Morales Meseguer
Murcia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Morales Meseguer (10)
2024
-
Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group
Clinical and Translational Oncology, Vol. 26, Núm. 1, pp. 171-177
2023
-
Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group
Clinical and Translational Oncology, Vol. 25, Núm. 10, pp. 3021-3031
-
Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study
PLoS ONE, Vol. 18, Núm. 5 May
2022
-
Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence
European Journal of Internal Medicine, Vol. 100, pp. 33-45
-
Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial
Thrombosis and haemostasis, Vol. 122, Núm. 10, pp. 1653-1661
2021
2020
-
A snapshot of cancer-associated thromboembolic disease in 2018–2019: First data from the TESEO prospective registry
European Journal of Internal Medicine, Vol. 78, pp. 41-49
-
High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1
European Journal of Cancer, Vol. 141, pp. 193-198
2018
2017
-
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681